Skip to main navigation Skip to search Skip to main content

ZNF683 (Hobit) Marks a CD8+T Cell Population Associated with Anti-Tumor Immunity Following Anti-PD-1 Therapy for Richter Syndrome

  • Camilla K. Lemvigh
  • , Erin Michelle Parry
  • , Stephanie L. Deng
  • , Nathan J. Dangle
  • , Neil Ruthen
  • , Binyamin A. Knisbacher
  • , Julien Broseus
  • , Sebastien Hergalant
  • , Romain Guieze
  • , Shuqiang Li
  • , Shanye Yin
  • , Teddy Huang
  • , Kenneth J. Livak
  • , Gad Getz
  • , Donna S. Neuberg
  • , Pierre Feugier
  • , Peter Kharchenko
  • , William G. Wierda
  • , Lars Rønn Olsen
  • , Nitin Jain
  • Catherine J. Wu
  • University of Texas MD Anderson Cancer Center
  • Massachusetts General Hospital/Harvard Medical School
  • Dana-Farber Cancer Institute
  • Broad Institute of Harvard University and Massachusetts Institute of Technology
  • University of Lorraine
  • CHU de Clermont-Ferrand

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalBlood
Volume140
Issue numberSuppl. 1
Pages (from-to)1807-1808
ISSN0006-4971
DOIs
Publication statusPublished - 2022
Event64th ASH Annual Meeting and Exposition - New Orleans, United States
Duration: 10 Dec 202213 Dec 2022
Conference number: 64

Conference

Conference64th ASH Annual Meeting and Exposition
Number64
Country/TerritoryUnited States
CityNew Orleans
Period10/12/202213/12/2022

Cite this